Format

Send to

Choose Destination
Subst Use Misuse. 2010 Aug;45(10):1509-24. doi: 10.3109/10826081003682107.

Validity of self-reported misuse of prescription opioid analgesics.

Author information

1
Purdue Pharma L.P., One Stamford Forum, Stamford, 06901-3431, USA.

Abstract

AIM:

To determine concurrent validity of self-reported misuse of prescription opioids.

DESIGN AND SETTING:

Cross-sectional study in five U.S. methadone maintenance programs.

PARTICIPANTS:

92 addicts.

MEASUREMENTS:

Self-reported questionnaire assessing past-month misuse of 14 opioid analgesics, and color photographs of five opioid analgesics with instructions to mark those used in the past month "to get high." Concordance between self-report and photograph endorsement was assessed via Kappa statistic.

FINDINGS:

29 respondents completed both questionnaire and photograph endorsements. Kappas were 0.62 (OxyContin), 0.59 (methadone), 0.49 (Dilaudid), and 0.46 (generic extended-release oxycodone).

CONCLUSIONS:

Good-to-fair concurrent validity of self-reported abuse was seen for OxyContin, methadone, Dilaudid, and generic extended-release oxycodone.

PMID:
20590372
DOI:
10.3109/10826081003682107
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center